Ceridian HCM Holding Inc (NYSE:CDAY) – Stock analysts at Jefferies Financial Group cut their Q2 2020 EPS estimates for shares of Ceridian HCM in a research note issued to investors on Tuesday, December 17th, according to Zacks Investment Research. Jefferies Financial Group analyst S. Samana now anticipates that the company will earn $0.06 per share for the quarter, down from their prior estimate of $0.07. Jefferies Financial Group currently has a “Buy” rating and a $73.00 target price on the stock. Jefferies Financial Group also issued estimates for Ceridian HCM’s Q3 2020 earnings at $0.08 EPS and Q4 2020 earnings at $0.07 EPS.
Ceridian HCM (NYSE:CDAY) last released its quarterly earnings results on Thursday, November 7th. The company reported $0.11 earnings per share for the quarter, topping analysts’ consensus estimates of $0.07 by $0.04. Ceridian HCM had a net margin of 11.34% and a return on equity of 2.24%. The business had revenue of $202.30 million during the quarter, compared to the consensus estimate of $196.52 million. During the same quarter last year, the company earned $0.10 earnings per share. The business’s quarterly revenue was up 13.6% compared to the same quarter last year.
CDAY has been the subject of a number of other research reports. Royal Bank of Canada began coverage on shares of Ceridian HCM in a report on Tuesday, December 3rd. They issued an “outperform” rating and a $71.00 price objective for the company. Credit Suisse Group raised their price target on shares of Ceridian HCM from $52.00 to $63.00 and gave the stock a “neutral” rating in a research report on Tuesday, December 24th. Citigroup raised shares of Ceridian HCM from a “neutral” rating to a “buy” rating and lifted their price target for the company from $52.00 to $58.00 in a report on Friday, October 25th. TheStreet upgraded shares of Ceridian HCM from a “d+” rating to a “c-” rating in a research note on Wednesday, November 20th. Finally, ValuEngine downgraded Ceridian HCM from a “hold” rating to a “sell” rating in a research note on Friday. One research analyst has rated the stock with a sell rating, six have given a hold rating and nine have issued a buy rating to the stock. Ceridian HCM currently has an average rating of “Buy” and an average price target of $58.07.
Shares of CDAY stock opened at $69.51 on Thursday. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.10 and a quick ratio of 1.10. Ceridian HCM has a 1-year low of $33.75 and a 1-year high of $70.05. The firm has a fifty day moving average of $62.71 and a two-hundred day moving average of $54.00. The firm has a market cap of $10.08 billion, a P/E ratio of -1,390.20 and a beta of 1.61.
In related news, Director Cannae Holdings, Inc. sold 5,000,000 shares of Ceridian HCM stock in a transaction dated Friday, November 15th. The shares were sold at an average price of $53.08, for a total value of $265,400,000.00. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 26.90% of the company’s stock.
Institutional investors and hedge funds have recently bought and sold shares of the stock. Price T Rowe Associates Inc. MD boosted its position in Ceridian HCM by 31.4% during the 2nd quarter. Price T Rowe Associates Inc. MD now owns 13,864,672 shares of the company’s stock worth $696,007,000 after acquiring an additional 3,312,089 shares during the period. Select Equity Group L.P. raised its stake in shares of Ceridian HCM by 32.4% during the third quarter. Select Equity Group L.P. now owns 8,434,199 shares of the company’s stock valued at $416,396,000 after purchasing an additional 2,064,472 shares in the last quarter. Vanguard Group Inc. raised its stake in shares of Ceridian HCM by 30.9% during the second quarter. Vanguard Group Inc. now owns 6,487,533 shares of the company’s stock valued at $325,674,000 after purchasing an additional 1,531,004 shares in the last quarter. BlackRock Inc. lifted its holdings in Ceridian HCM by 28.6% in the second quarter. BlackRock Inc. now owns 2,913,790 shares of the company’s stock worth $146,271,000 after purchasing an additional 647,177 shares during the period. Finally, Bamco Inc. NY lifted its holdings in Ceridian HCM by 8.2% in the second quarter. Bamco Inc. NY now owns 2,562,171 shares of the company’s stock worth $128,621,000 after purchasing an additional 195,002 shares during the period. Hedge funds and other institutional investors own 82.98% of the company’s stock.
Ceridian HCM Company Profile
Ceridian HCM Holding Inc operates as a human capital management (HCM) software company in the United States and internationally. The company offers Dayforce, a cloud HCM platform that provides human resources (HR), payroll, benefits, workforce management, and talent management functionality; and Powerpay, a cloud platform, which offers scalable and straightforward payroll and HR solutions.